Dynamic Slide Library Index

CLINICAL TRIALS


Opioids

Fentanyl Buccal Tablet for BTP in Opioid-Tolerant Patients
Fentanyl Buccal Tablet for BTP Results: Change in Mean PID Score
Fentanyl Buccal Tablet for BTP: Conclusions

Triptans


Antidepressants


Anticonvulsants

 

DISEASE MANAGEMENT


Migraine

Key Learning Points From: Women With Migraine:Effective Strategies for Positive Outcomes
Headache Recurrence
Principles of Preventive Drug Treatment
Tailor Therapy Appropriately to Comorbid Conditions
Preventive Medication Groups
Differentiating Migraine and Sinus HA: HA Is Minor AAO-HNS Sinusitis Criteria
Medication OveruseHeadache (MOH) Management
Menstrually Related Migraine (MRM) Occurs Days -2 to +3
Risk Factors for Strokes in Migraineurs With Auras Who Use OCs
MRM: Treatment Approach
Short-term Prevention Strategies: 1 or more RCTs Support Efficacy
Migraine Impact and Prevalence (American Migraine Study II)
IHS Classification: ICHD-2
Tools for Migraine Diagnosis/Disability
Migraine Snapshot
Migraine Triggers
Differentiating Migraine andTension-Type Headaches
Acute Migraine Medications
Comparison of Triptans

Neuropathic Pain

Antidepressants in Neuropathic Pain Disorders*
Pain Treatment Continuum
Duloxetine: Metabolism and Drug Interactions
Functional Magnetic Resonance Imaging (fMRI) and the Neuropathic Pain Process
Duloxetine Works Centrally in Descending Pathways and Spinal Cord
Duloxetine
Duloxetine: Metabolism and Drug Interactions
Anticonvulsant Drugs for Neuropathic Pain Disorders
Common Adverse Effects Associated With Anticonvulsant Use
Pregabalin: Improvement in Quality of Life for Postherpetic Neuralgia
Pharmacologic Agents Affect Pain Differently
Antidepressants in Neuropathic Pain Disorders*
Lidocaine Patch 5% Works Locally Through Sodium Channels
Efficacy of Lidocaine Patch 5% in Postherpetic Neuralgia
Lidocaine Patch 5%
Efficacy of Tramadol in Painful Polyneuropathy*
Mechanisms of Action: Analgesic Agents
Tricyclic Antidepressants: Adverse Effects
FDA-Approved Treatments for Neuropathic Pain
Gabapentin Works Centrally Through Calcium Channels
Gabapentin
Gabapentin in the Treatment of Painful Diabetic Neuropathy*
Amitryptyline – Sites of Action
Pharmacologic Treatment Options
Treatment Guidelines for Diabetic Peripheral Neuropathic Pain
Herpes Zoster Vaccine: Zostavax
Functional Magnetic Resonance Imaging (fMRI) and the Neuropathic Pain Process

Opioid Analgesia

Use of Opioids for Chronic Pain: A Study of PCP Behaviors
Use of Opioids for Chronic Pain: Top 5 PCP Prescribing Concerns
Use of Opioids for Chronic Pain: PCP Practice Behaviors
The Facts: Cases Against Doctors
The Facts: Cases Against Doctors (cont’d)
The Facts: Cases Against Doctors (cont’d)
Ground Rules for Prescribing Opioid Analgesics
Newly Approved Opioids
Mu-opioid Receptor Activation and Incomplete Cross Tolerance
Advances in Opioid Analgesia: Maximizing Benefit While Minimizing Risk
Algorithm for Opioid Treatment of Chronic Pain
Patient Selection
Pain Assessment: Making the Diagnosis
Alternatives to Opioid Therapy
Initiating Opioid Therapy
Create an Exit Strategy
Patient Reassessment Model
Deciding to Convert From a Short-acting to a Long-acting Opioid
Mu-opioid Receptor Polymorphisms
Management of Opioid Side Effects
Management of Opioid Side Effects (cont’d)
Addiction
Pseudoaddiction
Aberrant Drug-taking Behaviors
Differential Diagnosis of Aberrant Drug-taking Behavior
Continue Opioid Therapy
Regulatory Issues
Exit Strategy
Opioid Titration
Opioid Titration Protocol
Opioid Conversion
Opioid Rotation
Mu-agonist Dose Chart*
Opioid Conversion Calculator
Analgesic Equivalence Calculation
Rotating From Morphine to Oxymorphone ER
Rotating From Morphine to Transdermal Fentanyl

Pain Assessment

Activities Impaired by Increasing Pain Severity*
Antidepressants in Neuropathic Pain Disorders*
Patient Pain Diary
Pain Perception
Pain Assessment: New Strategies to Improve Clinical Outcome
Chronic Pain Affects All Aspects of Patient’s Life
What Are the Goals of Clinical Assessment?
Primary Care Physician Coordination of the Multidisciplinary Team
Assessing the Patient With Pain
Physiology of Pain Perception
Pain Assessment Scales
Multilanguage Pain Scales
Neuropathic Pain Questionnaire Short Form
Clinical Assessment: Neurologic History
Clinical Assessment: Psychosocial History
Clinical Assessment: Neurologic Examination
Clinical Assessment: Neurologic Examination (cont'd)
Pain Assessment: Medical History Findings Associated With Substance Use Disorders
Pain Assessment: Medical History Findings Associated With Substance Use Disorders
Diagnostic Studies and Limitations
Functional Magnetic Resonance Imaging (fMRI) and the Neuropathic Pain Process
Pain Assessment: Making the Diagnosis
Pain Assessment: When to Refer?

Low Back Pain

Key Points for Clinically Managing Chronic Low Back Pain
Red Flags
Neurologic History
Musculoskeletal Examination
Neurologic Exam Determines Presence/Absence and Level of Radiculopathy and Myelopathy
Medical Red Flags = Early Warning
When to Refer for Surgical Consultation
Surgery Options
Pharmacotherapy Options*
Pharmacologic Agents Affect Pain Differently
Treatment Strategies for LBP
Natural History of LBP
Treatment Strategies for LBP (cont’d)
Interventional Treatment Options
Physical Treatment Options
Nociceptive vs Neuropathic LBP
Referred LBP Is Remote From Source of Pain
Radicular LBP Results From Irritation of Spinal Nerve or Its Roots
LBP Patient Treatment Prototypes
Structure of Lumbar Spine
Sources of LBP
Considerations in the Clinical Assessment and Diagnosis of Chronic LBP